Loratadine and Sleep talking - a phase IV clinical study of FDA data

Summary:

Sleep talking is reported as a side effect among people who take Loratadine (loratadine), especially for people who are female, 60+ old, also take Gabapentin, and have Pain.

The phase IV clinical study analyzes which people have Sleep talking when taking Loratadine. It is created by eHealthMe based on reports of 53,991 people who have side effects when taking Loratadine from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Sleep talking?

Sleep talking (talking during sleeping) is found to be associated with 283 drugs and 408 conditions by eHealthMe. Check the latest studies of Sleep talking.

On Jul, 09, 2026

53,991 people reported to have side effects when taking Loratadine.
Among them, 30 people (0.06%) have Sleep talking.

Among these 30 people:

What is the gender of people who have Sleep talking when taking Loratadine? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Sleep talking when taking Loratadine? *

What are other drugs people take besides Loratadine? *

Acetaminophen And Codeine Phosphate: 12 people, 40.00%
Gabapentin: 12 people, 40.00%
Diclofenac: 10 people, 33.33%
Sumatriptan: 8 people, 26.67%
Oxycodone: 8 people, 26.67%
Zyrtec: 8 people, 26.67%
Ultram: 7 people, 23.33%
Humira: 7 people, 23.33%
Insulin: 7 people, 23.33%
Dovonex: 7 people, 23.33%

What are other side effects people have besides Sleep talking? *

Sleep Walking (walking during sleep): 13 people, 43.33%
Fall: 12 people, 40.00%
Weakness: 11 people, 36.67%
Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 33.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 26.67%
Hypoglycemia (low blood sugar): 8 people, 26.67%
Mood Swings (an extreme or rapid change in mood): 8 people, 26.67%
Insomnia (sleeplessness): 8 people, 26.67%
Stress And Anxiety: 8 people, 26.67%
Hyperkeratosis (thickening of the outer layer of the skin): 8 people, 26.67%

What are the existing conditions these people have? *

Pain: 16 people, 53.33%
Headache (pain in head): 10 people, 33.33%
Hypersensitivity: 10 people, 33.33%
Migraine (headache): 8 people, 26.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 23.33%
Psoriasis (immune-mediated disease that affects the skin): 7 people, 23.33%
Intestinal Functional Disorder: 6 people, 20.00%
Facial Pain: 6 people, 20.00%
Constipation: 4 people, 13.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and have Sleep talking?

- Check whether Sleep talking is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loratadine:

Loratadine (56,314 reports)

Sleep talking treatments and more:

Sleep talking (2,128 reports)

Browse all side effects of Loratadine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sleep talking:

Sleep talking (283 drugs)

Browse all the conditions that are associated with Sleep talking:

Sleep talking (408 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Loratadine) and Loratadine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.